BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18279814)

  • 1. Interleukin-6-572C>G polymorphism-association with inflammatory variables in Korean men with coronary artery disease.
    Jang Y; Kim OY; Hyun YJ; Chae JS; Koh SJ; Heo YM; Choi D; Shin DJ; Huttner K; Lee JH
    Transl Res; 2008 Mar; 151(3):154-61. PubMed ID: 18279814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the IL-6 -572C>G polymorphism on inflammatory markers according to cigarette smoking in Korean healthy men.
    Shin KK; Jang Y; Koh SJ; Chae JS; Kim OY; Park S; Choi D; Shin DJ; Kim HJ; Lee JH
    Cytokine; 2007 Aug; 39(2):116-22. PubMed ID: 17689974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension.
    Wong LY; Leung RY; Ong KL; Cheung BM
    J Hum Hypertens; 2007 Nov; 21(11):875-82. PubMed ID: 17508011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 (IL-6) -174G/C genomic polymorphism contribution to the risk of coronary artery disease in a Chinese population.
    Mao L; Geng GY; Han WJ; Zhao MH; Wu L; Liu HL
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans.
    Koh SJ; Jang Y; Hyun YJ; Park JY; Song YD; Shin KK; Chae JS; Kim BK; Ordovas JM; Lee JH
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):238-44. PubMed ID: 18573122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.
    Humphries SE; Luong LA; Ogg MS; Hawe E; Miller GJ
    Eur Heart J; 2001 Dec; 22(24):2243-52. PubMed ID: 11728144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 6(-174G/C) variant and its circulating levels in coronary artery disease patients and their first degree relatives.
    Galimudi RK; Spurthi MK; Padala C; Kumar KG; Mudigonda S; Reddy SG; Aiyengar MT; Sahu SK; Rani SH
    Inflammation; 2014 Apr; 37(2):314-21. PubMed ID: 24072607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter variants of TNF-α rs1800629 and IL-10 rs1800871 are independently associated with the susceptibility of coronary artery disease in north Indian.
    Kumari R; Kumar S; Ahmad MK; Singh R; Kant Kumar S; Pradhan A; Chandra S; Kumar S
    Cytokine; 2018 Oct; 110():131-136. PubMed ID: 29734056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6-174G/C and IL-6-572C/G polymorphisms are associated with increased risk of coronary artery disease.
    Li L; Li E; Zhang LH; Jian LG; Liu HP; Wang T
    Genet Mol Res; 2015 Jul; 14(3):8451-7. PubMed ID: 26345772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Hs-CRP levels and interleukin 18 (-137G/C) promoter polymorphism in risk prediction of coronary artery disease in first degree relatives.
    G RK; K MS; G KK; Kurapati M; M S; T MA; P C; G SR; S N; P K; K SS; H SR
    PLoS One; 2015; 10(3):e0120359. PubMed ID: 25822970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 -572C/G polymorphism is associated with serum interleukin-6 levels and risk of idiopathic pulmonary arterial hypertension.
    Fang M; Huang Y; Zhang Y; Ning Z; Zhu L; Li X
    J Am Soc Hypertens; 2017 Mar; 11(3):171-177. PubMed ID: 28229900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease.
    Jang Y; Chae JS; Hyun YJ; Koh SJ; Kim JY; Ko MJ; Rim SJ; Shin HJ; Ordovas JM; Lee JH
    Clin Sci (Lond); 2007 Oct; 113(8):349-56. PubMed ID: 17504241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines.
    Georges JL; Rupprecht HJ; Blankenberg S; Poirier O; Bickel C; Hafner G; Nicaud V; Meyer J; Cambien F; Tiret L;
    Am J Cardiol; 2003 Sep; 92(5):515-21. PubMed ID: 12943869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The -174 G>C Interleukin-6 Gene Polymorphism is Associated with Angiographic Progression of Coronary Artery Disease over a 4-Year Period.
    Toutouzas K; Klettas D; Anousakis-Vlachochristou N; Melidis K; Azilazian Z; Asimomiti M; Karanasos A; Spanos A; Tsiamis E; Nihoyannopoulos P; Tousoulis D
    Hellenic J Cardiol; 2017; 58(1):80-86. PubMed ID: 28212870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of interleukin-6 gene promoter polymorphism with coronary artery disease in Pakistani families.
    Satti HS; Hussain S; Javed Q
    ScientificWorldJournal; 2013; 2013():538365. PubMed ID: 24363620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of interleukin 6 -174 G/C polymorphism with coronary artery disease and circulating IL-6 levels: a systematic review and meta-analysis.
    Rai H; Colleran R; Cassese S; Joner M; Kastrati A; Byrne RA
    Inflamm Res; 2021 Dec; 70(10-12):1075-1087. PubMed ID: 34595552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interleukin-6 gene polymorphisms in the risk of coronary artery disease.
    Wang K; Dong PS; Zhang HF; Li ZJ; Yang XM; Liu H
    Genet Mol Res; 2015 Apr; 14(2):3177-83. PubMed ID: 25966083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease.
    Latkovskis G; Licis N; Kalnins U
    Eur J Immunogenet; 2004 Oct; 31(5):207-13. PubMed ID: 15379752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).
    Tsimikas S; Duff GW; Berger PB; Rogus J; Huttner K; Clopton P; Brilakis E; Kornman KS; Witztum JL
    J Am Coll Cardiol; 2014 May; 63(17):1724-34. PubMed ID: 24530664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.